A Single-blind Study to Evaluate the Safety Tolerability and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine

  • STATUS
    Recruiting
  • participants needed
    27
  • sponsor
    U.S. Army Medical Research and Development Command
Updated on 18 January 2021
Investigator
Kristopher Paolino, MD
Primary Contact
WRAIR Clinical Trials Center (6.2 mi away) Contact

Summary

This is a single-center, randomized, single-blinded study of the Hantaan virus HTNV DNA vaccine alone, Puumala virus PUUV DNA vaccine alone, and mixed Hantaan/Puumala HTNV/PUUV DNA vaccines delivered intramuscularly IM by the needle-free PharmaJet Stratus DSJI device.

Details
Treatment Hantaan Vaccine:, Puumala Vaccine, Hantaan/Puumala Vaccine
Clinical Study IdentifierNCT02776761
SponsorU.S. Army Medical Research and Development Command
Last Modified on18 January 2021

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet